Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
Clinical Nephrology
|
October 1, 1991
SCH 34826: an overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator
E J Sybertz
Federation Proceedings
|
February 1, 1983
Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers
T Baum, E J Sybertz
The American Journal of Medicine
|
October 17, 1983
Pharmacology of labetalol in experimental animals
T Baum, E J Sybertz
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1977
Facilitation of Chemoreceptor-induced reflex vasoconstriction by intravertebral arterial administration of clonidine
E J Sybertz, B G Zimmerman
The American Journal of Cardiology
|
June 5, 1989
Preclinical pharmacologic properties of dilevalol, an antihypertensive agent possessing selective beta 2 agonist-mediated vasodilation and beta antagonism
E J Sybertz, R W Watkins
Archives Internationales De Pharmacodynamie Et De Therapie
|
November 1, 1985
The role of Na+-K+ -ATPase in the vasorelaxant actions of synthetic atrial natriuretic factor
E J Sybertz, D M Desiderio
Clinical and Experimental Hypertension
|
January 1, 1980
The role of alpha receptors in the facilitation of the chemoreflex and inhibition of the carotid occlusion reflex by clonidine
E J Sybertz, B G Zimmerman
Clinical and Experimental Hypertension
|
January 1, 1981
Influence of angiotensin converting enzyme inhibition with captopril on blood pressure and adrenergic function in normal and sodium restricted rats
E J Sybertz, C S Sabin, R Moran
Archives Internationales De Pharmacodynamie Et De Therapie
|
June 1, 1987
Comparative renal effects of calcium channel blockers in conscious spontaneously hypertensive rats
S Vemulapalli, P J Chiu, E J Sybertz
Life Sciences
|
July 21, 1986
A post-calcium site of action for HA1004, a novel vasculorelaxant
P J Chiu, G Tetzloff, E J Sybertz
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
Clinical Nephrology
|
October 1, 1991
SCH 34826: an overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator
E J Sybertz
Federation Proceedings
|
February 1, 1983
Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers
T Baum, E J Sybertz
The American Journal of Medicine
|
October 17, 1983
Pharmacology of labetalol in experimental animals
T Baum, E J Sybertz
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1977
Facilitation of Chemoreceptor-induced reflex vasoconstriction by intravertebral arterial administration of clonidine
E J Sybertz, B G Zimmerman
The American Journal of Cardiology
|
June 5, 1989
Preclinical pharmacologic properties of dilevalol, an antihypertensive agent possessing selective beta 2 agonist-mediated vasodilation and beta antagonism
E J Sybertz, R W Watkins
Archives Internationales De Pharmacodynamie Et De Therapie
|
November 1, 1985
The role of Na+-K+ -ATPase in the vasorelaxant actions of synthetic atrial natriuretic factor
E J Sybertz, D M Desiderio
Clinical and Experimental Hypertension
|
January 1, 1980
The role of alpha receptors in the facilitation of the chemoreflex and inhibition of the carotid occlusion reflex by clonidine
E J Sybertz, B G Zimmerman
Clinical and Experimental Hypertension
|
January 1, 1981
Influence of angiotensin converting enzyme inhibition with captopril on blood pressure and adrenergic function in normal and sodium restricted rats
E J Sybertz, C S Sabin, R Moran
Archives Internationales De Pharmacodynamie Et De Therapie
|
June 1, 1987
Comparative renal effects of calcium channel blockers in conscious spontaneously hypertensive rats
S Vemulapalli, P J Chiu, E J Sybertz
Life Sciences
|
July 21, 1986
A post-calcium site of action for HA1004, a novel vasculorelaxant
P J Chiu, G Tetzloff, E J Sybertz
Page
of 8